ACRES Commercial Realty (ACR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Achieved a $3.3 million gain from the sale of a real estate investment in Greater Philadelphia during Q1 2026.
Book value per share reached $29.98 as of March 31, 2026, up 66% since 2020 and 5.2% year-over-year.
Completed a $1 billion CRE securitization (ACRES 2026-FL4/CRE CLO) with 86.5% leverage and a 30-month reinvestment period.
Announced internalization and merger, aligning management and employees as largest shareholders with over 40% interest; expected to close in Q3 2026.
Net CRE loan activity reached $374.4 million in Q1 2026, with a total CRE loan portfolio of $2.2 billion across 60 loans.
Financial highlights
GAAP net loss allocable to common shares was $1 million, or $0.16 per share, for Q1 2026, improving from a $5.9 million loss in Q1 2025.
Net interest income was $9.2 million in Q1 2026, up from $5.6 million in Q1 2025, driven by higher average loan balances.
EAD for Q1 2026 was $0.02 per share, compared to an EAD loss of $0.48 per share in Q4 2025.
Book value per share was $29.98 at March 31, 2026, down $0.03 from year-end 2025 but up from $28.50 in Q1 2025.
14% of the CRE loan portfolio is rated 4 or 5, indicating higher risk.
Outlook and guidance
Expect to see full run rate benefit from the new CRE securitization in Q2 2026.
Plan to pay dividends as earnings are realized post-merger, with a focus on distributing EAD.
Illustrative earnings scenarios project EAD EPS between $0.97 and $1.78 depending on portfolio size and leverage, but these are not formal guidance.
Management expects to close the internalization merger in Q3 2026, subject to shareholder approval.
Focus remains on managing liquidity, credit quality, and capital deployment amid market volatility and interest rate changes.
Latest events from ACRES Commercial Realty
- Internalization Merger and new equity plan proposed to enhance governance and align interests.ACR
Proxy filing11 May 2026 - Key votes include director elections, merger internalization, and new equity incentives.ACR
Proxy filing11 May 2026 - Stockholders to vote on internalization merger, new equity plan, and key governance proposals.ACR
Proxy filing1 May 2026 - $571M in new loans, $3M net loss, book value up to $30.01, and $1B CRE CLO closed.ACR
Q4 20255 Mar 2026 - Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 20242 Feb 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Book value and EAD rose on asset sales; strong multifamily loans and portfolio growth expected.ACR
Q4 202424 Dec 2025 - Annual meeting to vote on directors, Say on Pay, auditor, and highlight ESG and governance.ACR
Proxy Filing1 Dec 2025